mycinamicin VI

[(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-β-D-allopyranoside

ORPUAOXOPLNKNG-GEUQSOIWSA-N CHEBI:63285 0 Reactome links 2 studies

Metabolite details

Identifier: ORPUAOXOPLNKNG-GEUQSOIWSA-N
InChI Key: ORPUAOXOPLNKNG-GEUQSOIWSA-N
IUPAC name: [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-β-D-allopyranoside
Preferred name: mycinamicin VI
INN name: —
Synonym: —
ChEBI: CHEBI:63285

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth
Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

Wild_Type_vs_YQ2-gal
G1_PBS_vs_G2_DSS